S K Karuppangounder et al, 2021. Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection, Neurochem International, published online.
S M Carneiro et al, 2021. Neuroprotective properties of coffee: An update, Trends in Food Science & Technology, Volume
G Leodori et al, 2021. Salivary caffeine in Parkinson's disease, Scientific Reports, Volume 11 (1).
Y Chen et al, 2021. Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews, Journal of Parkinson’s Disease, published online.
X Ren & J F Chen, 2020. Caffeine and Parkinson’s disease: multiple benefits and emerging pathologies, Frontiers in Neuroscience, published online.
T Filippini et al, 2020. Dietary habits and risk of early-onset dementia in an Italian case-control study, Nutrients, Volume 12 (11)
T Wang et al, 2020. Association between coffee consumption and functional disability in the U.S older adults, British Journal of Nutrition, published online.
C T Hong et al, 2020. The effect of caffeine on the risk and progression of Parkinson's disease: a meta-analysis, Nutrients, Volume 12.
G Schepici et al, 2020. Caffeine: An overview of its beneficial effects in experimental models and clinical trials of Parkinson's disease, International Journal of Molecular Science, Volume 21 (13).
C H Tong et al, 2020. The Effect of Caffeine on the Risk and Progression of Parkinson's Disease: A Meta-Analysis, Nutrients, Volume 12 (6)
This information is intended for Healthcare professional audiences.
Please consider the environment before printing.